Turtlemint IPO Day 1: Issue opens today with GMP, review, and issue details

Turtlemint IPO opened for subscription on June 19 and will close on June 23, with a price band of ₹144 to ₹152 per share, valuing the company at over ₹4,500 crore at the upper end of the band. Ahead of the IPO, the company raised ₹397.20 crore from anchor investors by allotting 2.61 crore shares to 32 institutional investors, including ICICI Prudential Mutual Fund, Mirae Asset Mutual Fund, BNP Paribas, Edelweiss Mutual Fund, Bajaj Life Insurance, and Axis Max Life Insurance. Founded in 2015, Turtlemint operates a technology-driven insurance distribution platform that connects customers with insurance products through a large network of advisors. The company claims to have sold nearly 1.6 crore policies through more than 5 lakh advisors and served over 1.2 crore customers. The IPO allocation is reserved 75% for QIBs, 15% for NIIs, and 10% for retail investors, with shares expected to list on June 29. The current grey market premium (GMP) is around ₹2, indicating a likely listing price of ₹154.25, about 1.5% above the issue price, though the GMP trend has been weakening in recent sessions. The IPO consists of a fresh issue worth ₹660.72 crore and an offer-for-sale worth approximately ₹221.95 crore. The company plans to use the fresh issue proceeds for technology infrastructure expansion, product development, brand building, working capital requirements, and potential acquisitions. Analysts remain divided on the issue—some see strong long-term potential due to Turtlemint’s extensive advisor network, partnerships with 45 insurers, and opportunities in India's underpenetrated insurance market, while others remain cautious because the company is still loss-making, has experienced revenue volatility, and trades at a relatively high valuation. Overall, the IPO appears more suitable for long-term investors willing to take higher risks rather than those seeking immediate listing gains.